Opportunities Preloader

Please Wait.....

Report

High Potency APIs Market/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region - Global forecast to 2027

Market Report I 2022-05-17 I 270 Pages I MarketsandMarkets

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others.
"The innovative HPAPIs segment is expected to account for the largest share of the market in 2021"
Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments.
"The Synthetic APIs segment to account for the largest share of the market in 2021"
Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic APIs segment is expected to command the largest share in 2021. Ease of production and emergence of new molecules and technological advancements in synthesis are driving growth of synthetic HPAPI segment.
"The Oncology segment is expected to account for the largest share of the market in 2021"
Based on therapeutica application, the market is divided into oncology, hormonal imbalance, glaucoma, and other therapeutic applications. In 2021, Oncology segment is expected to account for the largest share in the market. The launch of new target therapies in addition to technological advancements and growing prevalence of cancer across the globe are driving growth of oncology segment.
"The Asia region is the fastest growing region of HPAPI market from 2022 to 2027"
HPAPI market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia to grow at the highest CAGR during the forecast period. High prevalence of chronic diseases, lifestyle diseases, age related diseases and government efforts for encouragement for the adoption of generics are some of the factors driving the growth of the market in Asia.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

-?By Respondent: Supply Side: 70%, Demand Side: 30%
-?By Designation: Managers: 65%, Executives: 25%, and CXOs: 10%
-?By Region: North America: 25%, Europe: 20%, Asia: 45%, and RoW: 10%
Prominent players in the HPAPI market include Pfizer, Inc. (US), F. Hoffmann-La Roche (Switzerland), Sanofi (France), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Novartis International AG (Switzerland), Boehringer Ingelheim International GmbH. (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), Merck & Co., Inc. (US), AbbVie (US), and Viatris Inc. (US).
Research Coverage:
The report segments the HPAPI market based on region (Asia, Europe, North America, and RoW), Type (Innovative, Generic), Type of Synthesis (Biotech, Synthetic), Type of manufacturer (Captive and Merchant), Therapeutic Applications (Oncology, Hormonal Imbalance, Glaucoma). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the HPAPI market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall HPAPI market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED 31
FIGURE 1 HPAPI MARKET: GEOGRAPHIC SCOPE 32
1.3.2 YEARS CONSIDERED 32
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 SUMMARY OF CHANGES 33
1.7 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
FIGURE 2 RESEARCH DESIGN 35
2.1 SECONDARY DATA 36
2.1.1 SECONDARY SOURCES 36
2.2 PRIMARY DATA 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: HPAPI MARKET 37
2.2.1 KEY DATA FROM PRIMARY SOURCES 38
2.2.2 PRIMARY INSIGHTS 38
2.3 MARKET SIZE ESTIMATION 39
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 40
2.4 MARKET GROWTH RATE PROJECTIONS 40
FIGURE 6 HPAPI MARKET: CAGR PROJECTIONS 41
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 7 DATA TRIANGULATION 42
2.6 RESEARCH ASSUMPTIONS 43
2.7 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 HPAPI MARKET, BY TYPE, 2021 VS. 2027 44
FIGURE 9 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2021 VS. 2027 45
FIGURE 10 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2021 VS. 2027 46
FIGURE 11 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2021 VS. 2027 47
FIGURE 12 GEOGRAPHIC SNAPSHOT OF HPAPI MARKET (2022-2027) 48
?
4 PREMIUM INSIGHTS 49
4.1 HPAPI: MARKET OVERVIEW 49
FIGURE 13 INCREASING DEMAND FOR ONCOLOGY DRUGS AND ANTIBODY-DRUG CONJUGATES TO DRIVE MARKET GROWTH 49
4.2 HPAPI MARKET, BY TYPE, (2021 VS. 2027) 50
FIGURE 14 INNOVATIVE HPAPIS TO DOMINATE THE GLOBAL MARKET IN 2027 50
4.3 HPAPI MARKET, BY TYPE OF SYNTHESIS, (2021 VS. 2027) 50
FIGURE 15 SYNTHETIC HPAPIS TO DOMINATE MARKET SHARE IN 2021 50
4.4 HPAPI MARKET BY THERAPEUTIC AREA (2021-2027) 51
FIGURE 16 ONCOLOGY SEGMENT TO REGISTER HIGHEST CAGR
DURING FORECAST PERIOD 51
4.5 GEOGRAPHICAL SNAPSHOT OF HPAPI MARKET 52
FIGURE 17 CHINA & INDIA TO REGISTER HIGH GROWTH RATES DURING 2022-2027 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 18 HPPAI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing demand for oncology drugs 54
TABLE 1 PIPELINE OF ONCOLOGY DRUGS (2021) 54
5.2.1.2 Growing demand for antibody-drug conjugates 55
5.2.1.3 Increasing focus of leading pharmaceutical companies on HPAPIs 55
5.2.1.4 Advancements in HPAPI manufacturing technologies 56
5.2.1.5 Growing focus on precision medicine 56
5.2.2 RESTRAINTS 57
5.2.2.1 Increasing requirement of large investments for employee safety 57
5.2.2.2 Discrepancies in HPAPI banding systems 57
5.2.2.3 Rising number of uncertainties associated with products 58
5.2.2.4 High risk of cross-contamination 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growing opportunities for CMOs and CDMOs 58
5.2.3.2 Increasing opportunities for companies in emerging markets 58
5.2.4 CHALLENGES 59
5.2.4.1 Need for appropriate process designs 59
5.2.4.2 Constant evolution of industry standards and technologies 59
5.3 IMPACT OF COVID-19 ON HPAPI MARKET 59
5.4 REGULATORY ANALYSIS 60
5.4.1 HANDLING HPAPI 60
5.4.2 THIRD PARTY CERTIFICATION 61
5.4.3 CONTAINMENT STRATEGIES 61
5.4.4 CHALLENGES 62
5.5 PORTER'S FIVE FORCES ANALYSIS 62
TABLE 2 HPAPI MARKET: PORTER'S FIVE FORCES ANALYSIS 62
5.5.1 THREAT OF NEW ENTRANTS 63
5.5.2 THREAT OF SUBSTITUTES 63
5.5.3 BARGAINING POWER OF SUPPLIERS 63
5.5.4 BARGAINING POWER OF BUYERS 63
5.5.5 DEGREE OF COMPETITION 63
5.6 TECHNOLOGY ANALYSIS 63
5.6.1 HANDLING POTENT COMPOUNDS 63
5.6.2 CONTROLS 64
5.6.3 SAFETY ASSESSMENT AND STANDARD OPERATING PROCEDURES 64
5.6.4 DEDICATED EQUIPMENT AND SYSTEMS 65
5.6.5 EXPERTISE AND TRAINING 65
5.6.6 COMBUSTIBLE DUST HANDLING 65
5.6.7 SUITABLE PERSONAL PROTECTIVE EQUIPMENT 65
6 HPAPI CLASSIFICATION AND OVERVIEW 66
6.1 INTRODUCTION 66
6.2 HPAPI INGREDIENTS CLASSIFICATION AS PER SAFEBRIDGE CONSULTANTS 66
TABLE 3 CATEGORIES OF HPAPIS 66
TABLE 4 POTENCY CLASSIFICATION SYSTEM 67
7 HPAPI MARKET, BY TYPE 69
7.1 INTRODUCTION 70
FIGURE 19 INNOVATIVE HPAPIS SEGMENT TO DOMINATE HPAPI MARKET 70
TABLE 5 HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 70
7.2 INNOVATIVE HPAPIS 71
TABLE 6 INNOVATIVE HPAPIS MARKET, BY REGION, 2020-2027 (USD MILLION) 71
TABLE 7 NORTH AMERICA: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 72
TABLE 8 EUROPE: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 72
TABLE 9 ASIA: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 73
7.3 GENERIC HPAPIS 73
TABLE 10 GENERIC HPAPIS MARKET, BY REGION, 2020-2027 (USD MILLION) 74
TABLE 11 NORTH AMERICA: GENERIC HPAPIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 74
TABLE 12 EUROPE: GENERIC HPAPIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 75
TABLE 13 ASIA: GENERIC HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 75
?
8 HPAPI MARKET, BY TYPE OF SYNTHESIS 76
8.1 INTRODUCTION 77
FIGURE 20 SYNTHETIC SEGMENT TO DOMINATE MARKET IN 2021 77
TABLE 14 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 77
8.2 SYNTHETIC APIS 78
TABLE 15 SYNTHETIC APIS MARKET, BY REGION, 2020-2027 (USD MILLION) 78
TABLE 16 NORTH AMERICA: SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 79
TABLE 17 EUROPE: SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 79
TABLE 18 ASIA: SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 80
8.2.1 SYNTHETIC APIS MARKET, BY TYPE 80
TABLE 19 SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 80
TABLE 20 INNOVATIVE SYNTHETIC APIS 81
TABLE 21 INNOVATIVE SYNTHETIC APIS MARKET, BY REGION,
2020-2027 (USD MILLION) 81
TABLE 22 NORTH AMERICA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 81
TABLE 23 EUROPE: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 82
TABLE 24 ASIA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 82
8.2.2 GENERIC SYNTHETIC APIS 83
TABLE 25 GENERIC SYNTHETIC APIS MARKET, BY REGION, 2020-2027 (USD MILLION) 83
TABLE 26 NORTH AMERICA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 83
TABLE 27 EUROPE: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 84
TABLE 28 ASIA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 84
8.3 BIOTECH APIS 85
TABLE 29 BIOTECH APIS MARKET, BY REGION, 2020-2027 (USD MILLION) 85
TABLE 30 NORTH AMERICA: BIOTECH APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 86
TABLE 31 EUROPE: BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 86
TABLE 32 ASIA: BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 87
8.3.1 BIOTECH APIS MARKET, BY TYPE 87
TABLE 33 BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 87
8.3.2 INNOVATIVE BIOTECH APIS 88
TABLE 34 INNOVATIVE BIOTECH APIS MARKET, BY REGION, 2020-2027 (USD MILLION) 88
TABLE 35 NORTH AMERICA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 88
TABLE 36 EUROPE: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 89
TABLE 37 ASIA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 89
8.3.3 BIOSIMILARS 90
TABLE 38 BIOSIMILARS MARKET, BY REGION, 2020-2027 (USD MILLION) 90
TABLE 39 NORTH AMERICA: BIOSIMILARS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 91
TABLE 40 EUROPE: BIOSIMILARS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 91
TABLE 41 ASIA: BIOSIMILARS INGREDIENTS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 92
8.3.4 BIOTECH APIS MARKET, BY PRODUCT 92
TABLE 42 BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 92
8.3.5 MONOCLONAL ANTIBODIES 93
TABLE 43 MONOCLONAL ANTIBODIES MARKET, BY REGION,
2020-2027 (USD MILLION) 93
8.3.6 VACCINES 93
TABLE 44 VACCINES MARKET, BY REGION, 2020-2027 (USD MILLION) 94
8.3.7 RECOMBINANT PROTEINS 94
TABLE 45 RECOMBINANT PROTEINS MARKET, BY REGION, 2020-2027 (USD MILLION) 95
9 HPAPI MARKET, BY TYPE OF MANUFACTURER 96
9.1 INTRODUCTION 97
FIGURE 21 CAPTIVE HPAPI MANUFACTURERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2021 97
TABLE 46 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION) 98
9.2 CAPTIVE API MANUFACTURERS 98
TABLE 47 CAPTIVE API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 99
TABLE 48 NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 99
TABLE 49 EUROPE: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 100
TABLE 50 ASIA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 100
9.3 MERCHANT API MANUFACTURERS 101
TABLE 51 MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 101
TABLE 52 NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 102
TABLE 53 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 102
TABLE 54 ASIA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 103
9.3.1 MERCHANT API MANUFACTURERS MARKET BY TYPE 103
TABLE 55 MERCHANT API MANUFACTURERS MARKET BY TYPE,
2020-2027 , (USD MILLION) 103
9.3.2 INNOVATIVE MERCHANT API MANUFACTURERS 104
TABLE 56 INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 104
TABLE 57 NORTH AMERICA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 104
TABLE 58 EUROPE: INNOVATIVE MERCHANT API MANUFACTURERS MARKET,
BY COUNTRY, 2020-2027 (USD MILLION) 105
TABLE 59 ASIA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 105
9.3.3 GENERIC MERCHANT API MANUFACTURERS 106
TABLE 60 GENERIC MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 106
TABLE 61 NORTH AMERICA: GENERIC MERCHANT API MANUFACTURERS MARKET,
BY COUNTRY, 2020-2027 (USD MILLION) 106
TABLE 62 EUROPE: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 107
TABLE 63 ASIA: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 107
9.3.4 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS 108
TABLE 64 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS,
2020-2027 , (USD MILLION) 108
9.3.5 SYNTHETIC API MANUFACTURERS 108
TABLE 65 SYNTHETIC API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 108
TABLE 66 NORTH AMERICA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 109
TABLE 67 EUROPE: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 109
TABLE 68 ASIA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 110
9.3.6 BIOTECH API MANUFACTURERS 110
TABLE 69 BIOTECH API MANUFACTURERS MARKET, BY REGION,
2020-2027 (USD MILLION) 111
TABLE 70 NORTH AMERICA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 111
TABLE 71 EUROPE: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 112
TABLE 72 ASIA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 112
10 HPAPI MARKET, BY THERAPEUTIC APPLICATION 113
10.1 INTRODUCTION 114
FIGURE 22 ONCOLOGY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 114
TABLE 73 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION) 115
10.2 ONCOLOGY 115
TABLE 74 HPAPI MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION) 116
TABLE 75 NORTH AMERICA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020-2027 (USD MILLION) 116
TABLE 76 EUROPE: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020-2027 (USD MILLION) 117
TABLE 77 ASIA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020-2027 (USD MILLION) 117
10.3 HORMONAL IMBALANCE 118
TABLE 78 HPAPI MARKET FOR HORMONAL IMBALANCE, BY REGION,
2020-2027 (USD MILLION) 118
TABLE 79 NORTH AMERICA: HPAPI MARKET FOR HORMONAL IMBALANCE,
BY COUNTRY, 2020-2027 (USD MILLION) 119
TABLE 80 EUROPE: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY,
2020-2027 (USD MILLION) 119
TABLE 81 ASIA: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY,
2020-2027 (USD MILLION) 120
10.4 GLAUCOMA 120
TABLE 82 HPAPI MARKET FOR GLAUCOMA, BY REGION, 2020-2027 (USD MILLION) 120
TABLE 83 NORTH AMERICA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020-2027 (USD MILLION) 121
TABLE 84 EUROPE: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020-2027 (USD MILLION) 121
TABLE 85 ASIA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020-2027 (USD MILLION) 122
10.5 OTHER THERAPEUTIC APPLICATIONS 122
TABLE 86 HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION,
2020-2027 (USD MILLION) 123
TABLE 87 NORTH AMERICA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 123
TABLE 88 EUROPE: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2020-2027 (USD MILLION) 124
TABLE 89 ASIA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 124
11 HPAPI MARKET, BY REGION 125
11.1 INTRODUCTION 126
TABLE 90 HPAPI MARKET, BY REGION, 2020-2027 (USD MILLION) 126
11.2 NORTH AMERICA 126
FIGURE 23 NORTH AMERICA: HPAPI MARKET SNAPSHOT 127
TABLE 91 NORTH AMERICA: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 128
TABLE 92 NORTH AMERICA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 128
TABLE 93 NORTH AMERICA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 129
TABLE 94 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION) 129
TABLE 95 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 130
TABLE 96 NORTH AMERICA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 130
TABLE 97 NORTH AMERICA: SYNTHETIC APIS INGREDIENTS MARKET, BY TYPE,
2020-2027 (USD MILLION) 131
TABLE 98 NORTH AMERICA: BIOTECH APIS MARKET, BY TYPE,
2020-2027 (USD MILLION) 131
TABLE 99 NORTH AMERICA: BIOTECH HPAPI MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 132
TABLE 100 NORTH AMERICA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 132
11.2.1 US 133
11.2.1.1 Increasing Investments in cancer research to drive market growth 133
TABLE 101 US: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 133
TABLE 102 US: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 134
TABLE 103 US: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 134
TABLE 104 US: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 135
TABLE 105 US: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 135
TABLE 106 US: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 136
TABLE 107 US: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION 136
TABLE 108 US: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 137
TABLE 109 US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION) 137
11.2.2 CANADA 138
11.2.2.1 The rising prevalence of cancer to drive market growth 138
TABLE 110 CANADA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 138
TABLE 111 CANADA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 138
TABLE 112 CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 139
TABLE 113 CANADA: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 139
TABLE 114 CANADA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 140
TABLE 115 CANADA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 140
TABLE 116 CANADA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 141
TABLE 117 CANADA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 141
TABLE 118 CANADA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 142
11.3 EUROPE 142
FIGURE 24 EUROPE: HPAPI MARKET SNAPSHOT 143
TABLE 119 EUROPE: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 144
TABLE 120 EUROPE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 144
TABLE 121 EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 145
TABLE 122 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 145
TABLE 123 EUROPE: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 146
TABLE 124 EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 146
TABLE 125 EUROPE: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 147
TABLE 126 EUROPE: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 147
TABLE 127 EUROPE: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 148
TABLE 128 EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 148
11.3.1 GERMANY 149
11.3.1.1 The strong focus on biotech and medical research
to drive market growth 149
TABLE 129 GERMANY: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 149
TABLE 130 GERMANY: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 150
TABLE 131 GERMANY: MERCHANT API MANUFACTURERS MARKET,
BY TYPE, 2020-2027 (USD MILLION) 150
TABLE 132 GERMANY: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 151
TABLE 133 GERMANY: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 151
TABLE 134 GERMANY: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 152
TABLE 135 GERMANY: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 152
TABLE 136 GERMANY: BIOTECH APIS MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 153
TABLE 137 GERMANY: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 153
11.3.2 FRANCE 154
11.3.2.1 The presence of many pharmaceutical companies coupled with the growing demand for novel cancer therapies to drive market growth 154
TABLE 138 FRANCE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 154
TABLE 139 FRANCE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 154
TABLE 140 FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 155
TABLE 141 FRANCE: MERCHANT HPAPI MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 155
TABLE 142 FRANCE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 156
TABLE 143 FRANCE: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 156
TABLE 144 FRANCE: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 157
TABLE 145 FRANCE: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 157
TABLE 146 FRANCE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 158
11.3.3 UK 158
11.3.3.1 Increasing in the demand for cancer therapies to drive market growth 158
TABLE 147 UK: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 158
TABLE 148 UK: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 159
TABLE 149 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 159
TABLE 150 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 160
TABLE 151 UK: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 160
TABLE 152 UK: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 153 UK: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 154 UK: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 162
TABLE 155 UK: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 162
11.3.4 ITALY 163
11.3.4.1 Robust generic API production capacities to drive the market growth 163
TABLE 156 ITALY: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 163
TABLE 157 ITALY: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 163
TABLE 158 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 164
TABLE 159 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 164
TABLE 160 ITALY: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 165
TABLE 161 ITALY: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 165
TABLE 162 ITALY: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 166
TABLE 163 ITALY: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 166
TABLE 164 ITALY: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 167
11.3.5 SPAIN 167
11.3.5.1 Developments in the ADC segment to drive market growth 167
TABLE 165 SPAIN: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 166 SPAIN: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 168
TABLE 167 SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 168
TABLE 168 SPAIN: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 169
TABLE 169 SPAIN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 169
TABLE 170 SPAIN: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 170
TABLE 171 SPAIN: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 170
TABLE 172 SPAIN: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 171
TABLE 173 SPAIN: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 171
11.3.6 REST OF EUROPE 171
TABLE 174 REST OF EUROPE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 175 REST OF EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 172
TABLE 176 REST OF EUROPE: MERCHANT API MANUFACTURERS MARKET,
BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 177 REST OF EUROPE: MERCHANT MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 173
TABLE 178 REST OF EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 174
TABLE 179 REST OF EUROPE: SYNTHETIC APIS MARKET, BY TYPE,
2020-2027 (USD MILLION) 174
TABLE 180 REST OF EUROPE: BIOTECH APIS MARKET, BY TYPE,
2020-2027 (USD MILLION) 175
TABLE 181 REST OF EUROPE: BIOTECH APIS MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 175
TABLE 182 REST OF EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 176
11.4 ASIA 176
FIGURE 25 ASIA: HPAPI MARKET SNAPSHOT 177
TABLE 183 ASIA: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 178
TABLE 184 ASIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 185 ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 179
TABLE 186 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 179
TABLE 187 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 180
TABLE 188 ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 180
TABLE 189 ASIA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
TABLE 190 ASIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
TABLE 191 ASIA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 182
TABLE 192 ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 182
11.4.1 JAPAN 183
11.4.1.1 Investments in the development of ADC products
to drive market growth 183
TABLE 193 JAPAN: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 183
TABLE 194 JAPAN: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 183
TABLE 195 JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 184
TABLE 196 JAPAN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 184
TABLE 197 JAPAN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 185
TABLE 198 JAPAN: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 185
TABLE 199 JAPAN: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 186
TABLE 200 JAPAN: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 186
TABLE 201 JAPAN: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 187
11.4.2 CHINA 187
11.4.2.1 Low labor costs, presence of well-equipped manufacturing plants to drive market growth 187
TABLE 202 CHINA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 187
TABLE 203 CHINA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 188
TABLE 204 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 188
TABLE 205 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 189
TABLE 206 CHINA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 189
TABLE 207 CHINA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 190
TABLE 208 CHINA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 190
TABLE 209 CHINA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 191
TABLE 210 CHINA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 191
11.4.3 INDIA 192
11.4.3.1 Increasing Investments in Oncology to drive market growth 192
TABLE 211 INDIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 212 INDIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 192
TABLE 213 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 193
TABLE 214 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 193
TABLE 215 INDIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 194
TABLE 216 INDIA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 194
TABLE 217 INDIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 218 INDIA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 195
TABLE 219 INDIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 196
11.4.4 REST OF ASIA 196
TABLE 220 REST OF ASIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 197
TABLE 221 REST OF ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 197
TABLE 222 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 198
TABLE 223 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 198
TABLE 224 REST OF ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020-2027 (USD MILLION) 199
TABLE 225 REST OF ASIA: SYNTHETIC APIS MARKET, BY TYPE,
2020-2027 (USD MILLION) 199
TABLE 226 REST OF ASIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 200
TABLE 227 REST OF ASIA: BIOTECH APIS MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 200
TABLE 228 REST OF ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 201
11.5 REST OF THE WORLD 201
FIGURE 26 REST OF THE WORLD: HPAPI MARKET SNAPSHOT 202
TABLE 229 ROW: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION) 202
TABLE 230 ROW: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020-2027 (USD MILLION) 203
TABLE 231 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020-2027 (USD MILLION) 203
TABLE 232 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 204
TABLE 233 ROW: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION) 204
TABLE 234 ROW: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 205
TABLE 235 ROW: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION) 205
TABLE 236 ROW: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 206
TABLE 237 ROW: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020-2027 (USD MILLION) 206
12 COMPETITIVE LANDSCAPE 207
12.1 OVERVIEW 207
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 207
FIGURE 27 KEY DEVELOPMENTS IN HPAPI MARKET, 2019-2022 207
12.3 MARKET SHARE ANALYSIS 208
FIGURE 28 HPAPI MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 208
TABLE 238 HPAPI MARKET: DEGREE OF COMPETITION 208
12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 209
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN HPAPI MARKET, 2019-2021 209
12.5 COMPANY EVALUATION QUADRANT 210
12.5.1 STARS 210
12.5.2 EMERGING LEADERS 210
12.5.3 PERVASIVE PLAYERS 210
FIGURE 30 HPAPI MARKET: COMPANY EVALUATION QUADRANT 211
12.6 FOOTPRINT OF COMPANIES 212
TABLE 239 PORTFOLIO ANALYSIS BY TYPE OF SYNTHESIS: HPAPI MARKET (2021) 212
TABLE 240 PORTFOLIO ANALYSIS BY TYPE OF MANUFACTURER: HPAPI MARKET (2021) 212
TABLE 241 PORTFOLIO ANALYSIS BY TYPE OF THERAPEUTIC APPLICATIONS: HPAPI MARKET (2021) 213
12.7 REGIONAL FOOTPRINT 214
TABLE 242 REGIONAL FOOTPRINT OF COMPANIES: HPAPI MARKET (2021) 214
12.8 COMPETITIVE SCENARIO 215
TABLE 243 PRODUCT LAUNCHES 215
TABLE 244 DEALS 216
?
13 COMPANY PROFILES 217
13.1 MAJOR PLAYERS 217
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 PFIZER INC. 217
TABLE 245 PFIZER INC.: BUSINESS OVERVIEW 217
FIGURE 31 PFIZER INC.: COMPANY SNAPSHOT (2021) 218
13.1.2 NOVARTIS INTERNATIONAL AG 224
TABLE 246 NOVARTIS INTERNATIONAL AG: BUSINESS OVERVIEW 224
FIGURE 32 NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT (2021) 225
13.1.3 SANOFI 228
TABLE 247 SANOFI: BUSINESS OVERVIEW 228
FIGURE 33 SANOFI: COMPANY SNAPSHOT (2021) 229
13.1.4 F. HOFFMANN-LA ROCHE 235
TABLE 248 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 235
FIGURE 34 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 236
13.1.5 BRISTOL-MYERS SQUIBB COMPANY 242
TABLE 249 BRISTOL-MYERS SQUIBB COMPANY: BUSINESS OVERVIEW 242
FIGURE 35 BRISTOL-MYERS SQUIBB COMPANY: COMPANY SNAPSHOT (2021) 242
13.1.6 BOEHRINGER-INGELHEIM 245
TABLE 250 BOEHRINGER-INGELHEIM: BUSINESS OVERVIEW 245
FIGURE 36 BOEHRINGER-INGELHEIM: COMPANY SNAPSHOT (2021) 246
13.1.7 TEVA PHARMACEUTICAL INDUSTRY LTD. 249
TABLE 251 TEVA PHARMACEUTICAL INDUSTRY LTD.: BUSINESS OVERVIEW 249
FIGURE 37 TEVA PHARMACEUTICAL INDUSTRY LTD.: COMPANY SNAPSHOT (2021) 249
13.1.8 ELI LILY AND COMPANY 253
TABLE 252 ELI LILY AND COMPANY: BUSINESS OVERVIEW 253
FIGURE 38 ELI LILY AND COMPANY: COMPANY SNAPSHOT (2021) 253
13.1.9 MERCK & CO., INC. 257
TABLE 253 MERCK & CO., INC.: BUSINESS OVERVIEW 257
FIGURE 39 MERCK & CO., INC.: COMPANY SNAPSHOT (2021) 258
13.1.10 ABBVIE INC. 262
TABLE 254 ABBVIE INC.: BUSINESS OVERVIEW 262
FIGURE 40 ABBVIE INC.: COMPANY SNAPSHOT (2021) 263
13.1.11 VIATRIS INC. 267
TABLE 255 VIATRIS INC.: BUSINESS OVERVIEW 267
FIGURE 41 VIATRIS INC.: COMPANY SNAPSHOT (2021) 268
13.1.12 BAYER 270
TABLE 256 BAYER AG: BUSINESS OVERVIEW 270
FIGURE 42 BAYER AG: COMPANY SNAPSHOT (2021) 271
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 273
14.1 DISCUSSION GUIDE 273
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 276
14.3 AVAILABLE CUSTOMIZATIONS 278
14.4 RELATED REPORTS 278
14.5 AUTHOR DETAILS 279

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW